Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

This strategic acquisition, which entails acquiring the perpetual licence of Velvette, aligns with Reliance's ongoing ...

Top start-up accelerators for tech companies in 2025Issued by Emerging SoftwareJohannesburg, 14 Feb 2025Visit our press officeStart-up accelerators are intensive, short-term programmes designed to ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...